KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY
Delisted
KDNY was delisted on the 10th of August, 2023.
151 hedge funds and large institutions have $1.08B invested in Chinook Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 70 increasing their positions, 30 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 135 → 151 (+16)
33% less funds holding in top 10
Funds holding in top 10: 9 → 6 (-3)
Holders
151
Holding in Top 10
6
Calls
$10.2M
Puts
$307K
Top Buyers
| 1 | +$20.2M | |
| 2 | +$17.9M | |
| 3 | +$13.4M | |
| 4 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$13.2M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$7.66M |
Top Sellers
| 1 | -$15.5M | |
| 2 | -$13.9M | |
| 3 | -$8.56M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$8.46M |
| 5 |
SCM
Suvretta Capital Management
New York
|
-$7.75M |